UQCRC1 and Parkinson disease: Weekly intranasal administration of mitochondria led to significant improvements in behavioral performance in both a neurotoxin-induced PD rat model (200 μg per rat for 3 months) [2] and a genetic PD mouse model harboring a UQCRC1 gene mutation (40 μg per mouse for 6 months).